Work

PHASE I DOSE ESCALATION TRIAL OF HuM 291, A HUMANIZED ANTI-CD3 ANTIBODY, IN LIVING DONOR KIDNEY RECIPIENTS

Year: 1999

Type: article

Study design: Clinical Trial

Source: Transplantation

DOI: 10.1097/00007890-199904150-00810

Authors: Douglas Norman, Flavio Vincenti, Angelo de Mattos, John Barry, Daniel Levitt, Nancy Wedel, Susan Light

Institutions: Oregon Health & Science University, University of California, San Francisco

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2000937536

FWCI:

Cites:

Cited by:

Related to: 10